Alexandros is an Editor for the BMC Series and the Editor of BMC Hematology since September 2017. Before joining BioMed Central, Alexandros completed his PhD in biomedical engineering at Imperial College London, UK and then worked for The Boston Consulting Group as a strategy consultant. Alexandros’ interests were shaped early on during his undergraduate studies, through his work on trans-cranial magnetic stimulation, which developed his passion for medical devices. During his PhD, his main research focus was the development of bio-inspired electronic solutions to treat prominent diseases and disorders, ranging from endocrine gland dysfunctions to skin inflammation. He concurrently worked on pro-bono consulting projects on a range of industries, including the synthetic biology industry. Alexandros is also a contributor to the BioMed Central blog network.
Hemostasis, thrombosis and vascular biology
Dr. Alejandro Lazo-Langner is an Associate Professor of Medicine, Oncology and Epidemiology and Biostatistics at Western University in Canada, where he is a hematologist specializing in thromboembolic diseases. He holds an MD from La Salle University School of Medicine in Mexico City and an MSc in Clinical Epidemiology from the University of Ottawa. He completed a 4-years Residency program in Internal Medicine and a Fellowship in Hematology at the Universidad Nacional Autónoma de México in Mexico City and a Clinical and Research Fellowship in Thrombosis at the University of Ottawa. His research interests are focused on determinants of thromboembolic diseases, observational studies and clinical trials in thromboembolic disease, risk-benefit analysis and decision making. His secondary research interests include clinical and observational studies involving hematological malignancies. He joined the Editorial Board of BMC Hematology in 2014.